Compendium of Cancer Genome Aberrations

BRST5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
← Older edit
VisualWikitext
No edit summary
No edit summary
 
(4 intermediate revisions by 4 users not shown)
Line 69: Line 69:
|
|
|-
|-
| [[BRST5:Sclerosing adenosis|Sclerosing adenosis]]||Disease||
|[[BRST5:Sclerosing adenosis|Sclerosing adenosis]]||Disease||
|
|
|
|
Line 262: Line 262:
|
|
|-
|-
|[[BRST5:Microinvasive carcinoma|Microinvasive carcinoma]]||Disease||
|[[BRST5:Microinvasive carcinoma|Microinvasive carcinoma]]||Disease||Hieu Nguyen
|
|9/23/2025
|
|
|
|
|PENDING
|
|
|Katherine Geiersbach
|
|
|
|
Line 354: Line 354:
|
|
|-
|-
|[[BRST5:Acinic cell carcinoma|Acinic cell carcinoma]]||Disease||Patricija Zot
|[[BRST5:Acinic cell carcinoma|Acinic cell carcinoma]]||Disease||
|2/28/2024
|
|
|
|
|
|PENDING
|
|
|Katherine Geiersbach
|
|
|
|
|-
|-
|[[BRST5:Adenoid cystic carcinoma|Adenoid cystic carcinoma]]||Disease||Katherine Geiersbach / Jun Liao
|[[BRST5:Adenoid cystic carcinoma|Adenoid cystic carcinoma]]||Disease||Katherine Geiersbach;
Jun Liao
|10/12/02022
|10/12/02022
|11/11/2023
|11/11/2023
Line 372: Line 373:
|2024 template added
|2024 template added
|-
|-
|[[BRST5:Secretory carcinoma|Secretory carcinoma]]||Disease||Hui Chen / Katherine Geiersbach
|[[BRST5:Secretory carcinoma|Secretory carcinoma]]||Disease||Hui Chen;
Katherine Geiersbach
|10/12/2022
|10/12/2022
|11/11/2023
|11/11/2023
Line 467: Line 469:
|
|
|-
|-
|[[BRST5:Fibroadenoma|Fibroadenoma]]||Disease||H. Evin Gulbahce / Patricija Zot
|[[BRST5:Fibroadenoma|Fibroadenoma]]|| ||
|
|
|
|
|
|
|PENDING
|
|
|
|
|
|
|2024 template added
|-
|-
|[[BRST5:Phyllodes tumour|Phyllodes tumour]]||Disease||Emilie Lalonde / H. Evin Gulbahce /Katherine Geiersbach
|[[BRST5:Phyllodes tumour|Phyllodes tumour]]||Disease||Emilie Lalonde;
H. Evin Gulbahce;
 
Katherine Geiersbach
|8/11/2023
|8/11/2023
|11/11/2023
|11/11/2023
Line 759: Line 764:
----
----
|-
|-
|[[BRST5:Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)]]||Disease||
|[[BRST5:Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)|Extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma)]]||Disease||[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|
|
|
|
Line 768: Line 773:
|
|
|-
|-
|[[BRST5:Follicular lymphoma|Follicular lymphoma]]||Disease||
|[[BRST5:Follicular lymphoma|Follicular lymphoma]]||Disease||[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|
|
|
|
Line 788: Line 793:
!'''Notes'''
!'''Notes'''
|-
|-
|[[BRST5:Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma]]||Disease||
|[[BRST5:Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma]]||Disease||[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|
|
|
|
Line 797: Line 802:
|
|
|-
|-
|[[BRST5:Burkitt lymphoma|Burkitt lymphoma]]||Disease||
|[[BRST5:Burkitt lymphoma|Burkitt lymphoma]]||Disease||[[HAEM5:Volunteer Assignments and Opportunities|See HAEM5 volunteer sheet for authorship status]]
|
|
|
|
Line 854: Line 859:
|
|
|-
|-
|[[BRST5:Invasive carcinoma|Invasive carcinoma]||Disease||
|[[BRST5:Invasive carcinoma|Invasive carcinoma]]||Disease||
|
|
|
|
Line 863: Line 868:
|
|
|-
|-
|[[BRST5:Metastases to the breast|Metastases to the breast]||Disease||
|[[BRST5:Metastases to the breast|Metastases to the breast]]||Disease||
|
|
|
|
Retrieved from "https://test.ccga.io/index.php/BRST5:Volunteer_Assignments_and_Opportunities"